Like a woman’s libido, the name of the new drug approved to treat female sexual dysfunction is hard to understand—let alone pronounce. Yes, as if women struggling with hypoactive sexual desire ...
Addyi is the first FDA-approved treatment for women's sexual dysfunction. Debra Dillo shares how her marriage has changed since she started the medication We had a wonderful family life growing up. I ...
Add Yahoo as a preferred source to see more of our stories on Google. Viagra, the little blue pill, has been a household name for more than a generation. And now women’s sexual health is finally ...
On December 15, 2025, the U.S. FDA approved Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65. Addyi was previously approved ...
WASHINGTON -- The Food and Drug Administration on Tuesday approved the first prescription drug designed to boost sexual desire in women, a milestone long sought by a pharmaceutical industry eager to ...
Addyi is the first and only FDA-approved, hormone-free pill clinically proven to treat low sexual desire in women RALEIGH, N.C., July 24, 2025 /PRNewswire/ -- Sprout Pharmaceuticals today announced ...
More than a decade ago, Addyi—marketed as the “female Viagra”—was approved amid political pressure, heavy lobbying, and a lot of hype. The problem then, as now, is simple: the drug barely works and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results